4.7 Review

EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Glioblastoma vaccine therapy disappointment in Phase III trial

Hemi Malkki

Nature Reviews Neurology (2016)

Review Oncology

Notcning on cancer's door: Notch signaling in brain tumors

Marcin Teodorczyk et al.

FRONTIERS IN ONCOLOGY (2015)

Review Oncology

Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma

Emily Padfield et al.

FRONTIERS IN ONCOLOGY (2015)

Article Hematology

EGFL7 ligates αvβ3 integrin to enhance vessel formation

Iva Nikolic et al.

Article Multidisciplinary Sciences

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

Deborah Huveldt et al.

PLOS ONE (2013)

Review Oncology

WNT signalling pathways as therapeutic targets in cancer

Jamie N. Anastas et al.

NATURE REVIEWS CANCER (2013)

Article Oncology

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

T. E. Taylor et al.

CURRENT CANCER DRUG TARGETS (2012)

Article Oncology

The regulation of cysteine cathepsins and cystatins in human gliomas

Boris Gole et al.

INTERNATIONAL JOURNAL OF CANCER (2012)

Article Biochemistry & Molecular Biology

EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway

R. Bonavia et al.

ONCOGENE (2012)

Article Multidisciplinary Sciences

Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis

Haizhong Feng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Oncology

Heterogeneity Maintenance in Glioblastoma: A Social Network

Rudy Bonavia et al.

CANCER RESEARCH (2011)

Article Multidisciplinary Sciences

Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells

Jingjing Hu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Cell Biology

Integrins

Malgorzata Barczyk et al.

CELL AND TISSUE RESEARCH (2010)

Review Oncology

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

Deric L. Wheeler et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2010)

Review Oncology

Integrins in cancer: biological implications and therapeutic opportunities

Jay S. Desgrosellier et al.

NATURE REVIEWS CANCER (2010)

Article Biotechnology & Applied Microbiology

Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

P. Pu et al.

CANCER GENE THERAPY (2009)

Review Oncology

Trafficking of receptor tyrosine kinases to the nucleus

Graham Carpenter et al.

EXPERIMENTAL CELL RESEARCH (2009)

Article Medicine, Research & Experimental

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

Melarkode S. Ramakrishnan et al.

Review Oncology

Src kinases as therapeutic targets for cancer

Lori C. Kim et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Review Biochemistry & Molecular Biology

Oncogenic EGFR Signaling Networks in Glioma

Paul H. Huang et al.

SCIENCE SIGNALING (2009)

Article Cell Biology

Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

Nuria de la Iglesia et al.

GENES & DEVELOPMENT (2008)

Review Cell Biology

The function of Stat3 in tumor cells and their microenvironment

Bernd Groner et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)

Article Multidisciplinary Sciences

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

Paul H. Huang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Clinical Neurology

Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival

Masahiro Mizoguchi et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Cell Biology

Integrin-regulated FAK-Src signaling in normal and cancer cells

Satyajit K. Mitra et al.

CURRENT OPINION IN CELL BIOLOGY (2006)

Article Anatomy & Morphology

Expression of urokinase-type plasminogen activator receptor (uPAR) in primary central nervous system neoplasms

M Salajegheh et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)

Review Oncology

PI3K/Akt signalling pathway and cancer

JAF Vara et al.

CANCER TREATMENT REVIEWS (2004)

Review Oncology

c-Src and cooperating partners in human cancer

R Ishizawar et al.

CANCER CELL (2004)

Article Multidisciplinary Sciences

Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization

MHH Schmidt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Review Oncology

Src family kinases in tumor progression and metastasis

JM Summy et al.

CANCER AND METASTASIS REVIEWS (2003)

Review Oncology

The phosphatidylinositol 3-kinase-AKT pathway in human cancer

I Vivanco et al.

NATURE REVIEWS CANCER (2002)

Article Oncology

PAI-1 and EGFR expression in adult glioma tumors: Toward a molecular prognostic classification

X Muracciole et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)

Article Biochemistry & Molecular Biology

Activation of extracellular-regulated kinases by normal and mutant EGF receptors

IAJ Lorimer et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)

Article Cell Biology

FAK integrates growth-factor and integrin signals to promote cell migration

DJ Sieg et al.

NATURE CELL BIOLOGY (2000)